Cancer Survivorship: A Primer to Improve Care

Cancer Survivorship: A Primer to Improve Care

Cancer survivors who complete their active treatment typically need surveillance for recurrence and for the development of secondary cancers, monitoring for late effects of cancer treatment, as well as routine preventive and primary care. As this population with unique needs continues to grow, providers must understand the compelling need to provide coordinated, comprehensive and personalized care to these patients. This online activity will introduce, highlight and encourage participants to utilize the emerging body of guidelines, tools, and resources that are available to optimize the coordination and delivery of survivorship care. Participants will learn to recognize evidence-based screening, prevention and management strategies for potential long-term, late effects and how to tailor these for patients at varying risks for problems.

Faculty

Larissa Nekhlyudov MD, MPH 
Dr. Larissa Nekhlyudov is a board-certified general internist at Brigham and Women’s Hospital. She received her medical degree from the Mount Sinai School of Medicine and completed residency training at the Yale Primary Care Program. In addition to being a primary care provider, Dr. Nekhlyudov is the Clinical Director of Internal Medicine for Cancer Survivors at Dana-Farber Cancer Institute. She has extensive experience in cancer-related research and education, particularly in improving the care of cancer survivors and the interplay between primary and oncology care. She also serves as Professor of Medicine at Harvard Medical School.

Ann H. Partridge, MD, MPH
Dr. Ann Partridge is a medical oncologist focusing on the care of adults with breast cancer. She received her medical degree from Cornell University Medical College, completed her residency in internal medicine at the Hospital of the University of Pennsylvania and later completed fellowships in medical oncology and hematology at Dana-Farber Cancer Institute. Dr. Partridge serves as Director of Adult Survivorship at Dana-Farber Cancer Institute and is Professor of Medicine at Harvard Medical School. She has a particular interest in the psychosocial, behavioral, and communication issues in breast cancer care and treatment.

Alicia Morgans, MD, MPH
Dr. Alicia Morgans is a Genitourinary Medical Oncologist and Medical Director of the Adult Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense. She also serves as Faculty of Medicine at Harvard Medical School.

Intended Audience
Primary care providers and other health care professionals.

Course Objectives

• Describe trends in cancer survivorship and the role of providers after initial cancer treatment. 
• Identify the medical and psychosocial needs of diverse cancer survivors and develop strategies to address those needs. 
• Apply updated evidence and tools to enhance the delivery and coordination of care for cancer survivors.

Course Fees
Massachusetts Medical Society (MMS) Physician Member: Free
MMS Resident/Student Member: Free
Non-Member Physician: Free
Non-Members Resident/Student: Free
Allied Health Professional/Other: Free

This webinar was supported by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement 1 NU58DP006271-01-00. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.

Format & Estimated Time to Complete
Slides and Audio (1 hour)  

Accreditation and Credit Information
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and the Massachusetts Department of Public Health. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement
The Massachusetts Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.

National Commission on Certification of Physicians Assistant (NCCPA)
Physician Assistants may claim a maximum of 1.00 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Exam/Assessment: A score of 70% or higher is required to receive AMA PRA Category 1 Credit™.

Activity Term
Original Release Date: August 2, 2022
Review Date (s): N/A
Termination Date: August 2, 2025

System Requirements
Desktops/Laptops
Windows 10
Mac OSX 10.6 higher

Most modern browsers including:
IE 11+
Firefox 18.0+
Chrome latest version
Safari 12+

Mobile/Tablet
iOS devices beginning with OS version 10 or higher (includes, iPhone, ipad and iTouch devices)